1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Polymerase Chain Reaction (PCR) 1.2.3 Microarray 1.2.4 Sequencing 1.2.5 Other 1.3 Market by Application 1.3.1 Global Pharmacogenomics (PGx) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular Diseases (CVD) 1.3.3 Central Nervous System (CNS) 1.3.4 Cancer/Oncology 1.3.5 Infectious Diseases 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmacogenomics (PGx) Market Perspective (2016-2027) 2.2 Pharmacogenomics (PGx) Growth Trends by Regions 2.2.1 Pharmacogenomics (PGx) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharmacogenomics (PGx) Historic Market Share by Regions (2016-2021) 2.2.3 Pharmacogenomics (PGx) Forecasted Market Size by Regions (2022-2027) 2.3 Pharmacogenomics (PGx) Industry Dynamic 2.3.1 Pharmacogenomics (PGx) Market Trends 2.3.2 Pharmacogenomics (PGx) Market Drivers 2.3.3 Pharmacogenomics (PGx) Market Challenges 2.3.4 Pharmacogenomics (PGx) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmacogenomics (PGx) Players by Revenue 3.1.1 Global Top Pharmacogenomics (PGx) Players by Revenue (2016-2021) 3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2016-2021) 3.2 Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue 3.4 Global Pharmacogenomics (PGx) Market Concentration Ratio 3.4.1 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics (PGx) Revenue in 2020 3.5 Pharmacogenomics (PGx) Key Players Head office and Area Served 3.6 Key Players Pharmacogenomics (PGx) Product Solution and Service 3.7 Date of Enter into Pharmacogenomics (PGx) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmacogenomics (PGx) Breakdown Data by Type 4.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2016-2021) 4.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2022-2027) 5 Pharmacogenomics (PGx) Breakdown Data by Application 5.1 Global Pharmacogenomics (PGx) Historic Market Size by Application (2016-2021) 5.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pharmacogenomics (PGx) Market Size (2016-2027) 6.2 North America Pharmacogenomics (PGx) Market Size by Type 6.2.1 North America Pharmacogenomics (PGx) Market Size by Type (2016-2021) 6.2.2 North America Pharmacogenomics (PGx) Market Size by Type (2022-2027) 6.2.3 North America Pharmacogenomics (PGx) Market Size by Type (2016-2027) 6.3 North America Pharmacogenomics (PGx) Market Size by Application 6.3.1 North America Pharmacogenomics (PGx) Market Size by Application (2016-2021) 6.3.2 North America Pharmacogenomics (PGx) Market Size by Application (2022-2027) 6.3.3 North America Pharmacogenomics (PGx) Market Size by Application (2016-2027) 6.4 North America Pharmacogenomics (PGx) Market Size by Country 6.4.1 North America Pharmacogenomics (PGx) Market Size by Country (2016-2021) 6.4.2 North America Pharmacogenomics (PGx) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharmacogenomics (PGx) Market Size (2016-2027) 7.2 Europe Pharmacogenomics (PGx) Market Size by Type 7.2.1 Europe Pharmacogenomics (PGx) Market Size by Type (2016-2021) 7.2.2 Europe Pharmacogenomics (PGx) Market Size by Type (2022-2027) 7.2.3 Europe Pharmacogenomics (PGx) Market Size by Type (2016-2027) 7.3 Europe Pharmacogenomics (PGx) Market Size by Application 7.3.1 Europe Pharmacogenomics (PGx) Market Size by Application (2016-2021) 7.3.2 Europe Pharmacogenomics (PGx) Market Size by Application (2022-2027) 7.3.3 Europe Pharmacogenomics (PGx) Market Size by Application (2016-2027) 7.4 Europe Pharmacogenomics (PGx) Market Size by Country 7.4.1 Europe Pharmacogenomics (PGx) Market Size by Country (2016-2021) 7.4.2 Europe Pharmacogenomics (PGx) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharmacogenomics (PGx) Market Size (2016-2027) 8.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type 8.2.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2016-2027) 8.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application 8.3.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2016-2027) 8.4 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region 8.4.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmacogenomics (PGx) Market Size (2016-2027) 9.2 Latin America Pharmacogenomics (PGx) Market Size by Type 9.2.1 Latin America Pharmacogenomics (PGx) Market Size by Type (2016-2021) 9.2.2 Latin America Pharmacogenomics (PGx) Market Size by Type (2022-2027) 9.2.3 Latin America Pharmacogenomics (PGx) Market Size by Type (2016-2027) 9.3 Latin America Pharmacogenomics (PGx) Market Size by Application 9.3.1 Latin America Pharmacogenomics (PGx) Market Size by Application (2016-2021) 9.3.2 Latin America Pharmacogenomics (PGx) Market Size by Application (2022-2027) 9.3.3 Latin America Pharmacogenomics (PGx) Market Size by Application (2016-2027) 9.4 Latin America Pharmacogenomics (PGx) Market Size by Country 9.4.1 Latin America Pharmacogenomics (PGx) Market Size by Country (2016-2021) 9.4.2 Latin America Pharmacogenomics (PGx) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmacogenomics (PGx) Market Size (2016-2027) 10.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type 10.2.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2016-2027) 10.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application 10.3.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2016-2027) 10.4 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country 10.4.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Introduction 11.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 Affymetrix, Inc. 11.2.1 Affymetrix, Inc. Company Details 11.2.2 Affymetrix, Inc. Business Overview 11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Introduction 11.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.2.5 Affymetrix, Inc. Recent Development 11.3 Assurex Health, Inc 11.3.1 Assurex Health, Inc Company Details 11.3.2 Assurex Health, Inc Business Overview 11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Introduction 11.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.3.5 Assurex Health, Inc Recent Development 11.4 Astrazeneca 11.4.1 Astrazeneca Company Details 11.4.2 Astrazeneca Business Overview 11.4.3 Astrazeneca Pharmacogenomics (PGx) Introduction 11.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.4.5 Astrazeneca Recent Development 11.5 GeneDX 11.5.1 GeneDX Company Details 11.5.2 GeneDX Business Overview 11.5.3 GeneDX Pharmacogenomics (PGx) Introduction 11.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.5.5 GeneDX Recent Development 11.6 Illumina, Inc. 11.6.1 Illumina, Inc. Company Details 11.6.2 Illumina, Inc. Business Overview 11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Introduction 11.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.6.5 Illumina, Inc. Recent Development 11.7 Laboratory Corporation of America Holdings 11.7.1 Laboratory Corporation of America Holdings Company Details 11.7.2 Laboratory Corporation of America Holdings Business Overview 11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Introduction 11.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.7.5 Laboratory Corporation of America Holdings Recent Development 11.8 Myriad Genetics, Inc. 11.8.1 Myriad Genetics, Inc. Company Details 11.8.2 Myriad Genetics, Inc. Business Overview 11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Introduction 11.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.8.5 Myriad Genetics, Inc. Recent Development 11.9 Pathway Genomics 11.9.1 Pathway Genomics Company Details 11.9.2 Pathway Genomics Business Overview 11.9.3 Pathway Genomics Pharmacogenomics (PGx) Introduction 11.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.9.5 Pathway Genomics Recent Development 11.10 Pfizer, Inc 11.10.1 Pfizer, Inc Company Details 11.10.2 Pfizer, Inc Business Overview 11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Introduction 11.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.10.5 Pfizer, Inc Recent Development 11.11 Qiagen, Inc. 11.11.1 Qiagen, Inc. Company Details 11.11.2 Qiagen, Inc. Business Overview 11.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Introduction 11.11.4 Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.11.5 Qiagen, Inc. Recent Development 11.12 Rocheg 11.12.1 Rocheg Company Details 11.12.2 Rocheg Business Overview 11.12.3 Rocheg Pharmacogenomics (PGx) Introduction 11.12.4 Rocheg Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.12.5 Rocheg Recent Development 11.13 Teva Pharmaceutical Industries Ltd. 11.13.1 Teva Pharmaceutical Industries Ltd. Company Details 11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Introduction 11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.14 Thermo Fisher Scientific 11.14.1 Thermo Fisher Scientific Company Details 11.14.2 Thermo Fisher Scientific Business Overview 11.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Introduction 11.14.4 Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.14.5 Thermo Fisher Scientific Recent Development 11.15 Transgenomic, Inc. 11.15.1 Transgenomic, Inc. Company Details 11.15.2 Transgenomic, Inc. Business Overview 11.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Introduction 11.15.4 Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) 11.15.5 Transgenomic, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Polymerase Chain Reaction (PCR) Table 3. Key Players of Microarray Table 4. Key Players of Sequencing Table 5. Key Players of Other Table 6. Global Pharmacogenomics (PGx) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Pharmacogenomics (PGx) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Pharmacogenomics (PGx) Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Pharmacogenomics (PGx) Market Share by Regions (2016-2021) Table 10. Global Pharmacogenomics (PGx) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Pharmacogenomics (PGx) Market Share by Regions (2022-2027) Table 12. Pharmacogenomics (PGx) Market Trends Table 13. Pharmacogenomics (PGx) Market Drivers Table 14. Pharmacogenomics (PGx) Market Challenges Table 15. Pharmacogenomics (PGx) Market Restraints Table 16. Global Pharmacogenomics (PGx) Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Pharmacogenomics (PGx) Market Share by Players (2016-2021) Table 18. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics (PGx) as of 2020) Table 19. Ranking of Global Top Pharmacogenomics (PGx) Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Pharmacogenomics (PGx) Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pharmacogenomics (PGx) Product Solution and Service Table 23. Date of Enter into Pharmacogenomics (PGx) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pharmacogenomics (PGx) Market Size by Type (2016-2021) (US$ Million) Table 26. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2016-2021) Table 27. Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Pharmacogenomics (PGx) Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Pharmacogenomics (PGx) Revenue Market Share by Application (2016-2021) Table 31. Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Pharmacogenomics (PGx) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Pharmacogenomics (PGx) Market Size by Type (2016-2021) (US$ Million) Table 34. North America Pharmacogenomics (PGx) Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Pharmacogenomics (PGx) Market Size by Application (2016-2021) (US$ Million) Table 36. North America Pharmacogenomics (PGx) Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Pharmacogenomics (PGx) Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Pharmacogenomics (PGx) Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Pharmacogenomics (PGx) Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Pharmacogenomics (PGx) Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Pharmacogenomics (PGx) Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Pharmacogenomics (PGx) Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Pharmacogenomics (PGx) Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Pharmacogenomics (PGx) Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Pharmacogenomics (PGx) Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Pharmacogenomics (PGx) Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Pharmacogenomics (PGx) Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Pharmacogenomics (PGx) Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Pharmacogenomics (PGx) Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Pharmacogenomics (PGx) Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2022-2027) & (US$ Million) Table 63. Abbott Laboratories Company Details Table 64. Abbott Laboratories Business Overview Table 65. Abbott Laboratories Pharmacogenomics (PGx) Product Table 66. Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 67. Abbott Laboratories Recent Development Table 68. Affymetrix, Inc. Company Details Table 69. Affymetrix, Inc. Business Overview Table 70. Affymetrix, Inc. Pharmacogenomics (PGx) Product Table 71. Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 72. Affymetrix, Inc. Recent Development Table 73. Assurex Health, Inc Company Details Table 74. Assurex Health, Inc Business Overview Table 75. Assurex Health, Inc Pharmacogenomics (PGx) Product Table 76. Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 77. Assurex Health, Inc Recent Development Table 78. Astrazeneca Company Details Table 79. Astrazeneca Business Overview Table 80. Astrazeneca Pharmacogenomics (PGx) Product Table 81. Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 82. Astrazeneca Recent Development Table 83. GeneDX Company Details Table 84. GeneDX Business Overview Table 85. GeneDX Pharmacogenomics (PGx) Product Table 86. GeneDX Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 87. GeneDX Recent Development Table 88. Illumina, Inc. Company Details Table 89. Illumina, Inc. Business Overview Table 90. Illumina, Inc. Pharmacogenomics (PGx) Product Table 91. Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 92. Illumina, Inc. Recent Development Table 93. Laboratory Corporation of America Holdings Company Details Table 94. Laboratory Corporation of America Holdings Business Overview Table 95. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product Table 96. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 97. Laboratory Corporation of America Holdings Recent Development Table 98. Myriad Genetics, Inc. Company Details Table 99. Myriad Genetics, Inc. Business Overview Table 100. Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 101. Myriad Genetics, Inc. Recent Development Table 102. Pathway Genomics Company Details Table 103. Pathway Genomics Business Overview Table 104. Pathway Genomics Pharmacogenomics (PGx) Product Table 105. Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 106. Pathway Genomics Recent Development Table 107. Pfizer, Inc Company Details Table 108. Pfizer, Inc Business Overview Table 109. Pfizer, Inc Pharmacogenomics (PGx) Product Table 110. Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 111. Pfizer, Inc Recent Development Table 112. Qiagen, Inc. Company Details Table 113. Qiagen, Inc. Business Overview Table 114. Qiagen, Inc. Pharmacogenomics (PGx) Product Table 115. Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 116. Qiagen, Inc. Recent Development Table 117. Rocheg Company Details Table 118. Rocheg Business Overview Table 119. Rocheg Pharmacogenomics (PGx) Product Table 120. Rocheg Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 121. Rocheg Recent Development Table 122. Teva Pharmaceutical Industries Ltd. Company Details Table 123. Teva Pharmaceutical Industries Ltd. Business Overview Table 124. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product Table 125. Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 126. Teva Pharmaceutical Industries Ltd. Recent Development Table 127. Thermo Fisher Scientific Company Details Table 128. Thermo Fisher Scientific Business Overview Table 129. Thermo Fisher Scientific Pharmacogenomics (PGx) Product Table 130. Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 131. Thermo Fisher Scientific Recent Development Table 132. Transgenomic, Inc. Company Details Table 133. Transgenomic, Inc. Business Overview Table 134. Transgenomic, Inc. Pharmacogenomics (PGx) Product Table 135. Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2016-2021) & (US$ Million) Table 136. Transgenomic, Inc. Recent Development Table 137. Research Programs/Design for This Report Table 138. Key Data Information from Secondary Sources Table 139. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmacogenomics (PGx) Market Share by Type: 2020 VS 2027 Figure 2. Polymerase Chain Reaction (PCR) Features Figure 3. Microarray Features Figure 4. Sequencing Features Figure 5. Other Features Figure 6. Global Pharmacogenomics (PGx) Market Share by Application: 2020 VS 2027 Figure 7. Cardiovascular Diseases (CVD) Case Studies Figure 8. Central Nervous System (CNS) Case Studies Figure 9. Cancer/Oncology Case Studies Figure 10. Infectious Diseases Case Studies Figure 11. Other Case Studies Figure 12. Pharmacogenomics (PGx) Report Years Considered Figure 13. Global Pharmacogenomics (PGx) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Pharmacogenomics (PGx) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Pharmacogenomics (PGx) Market Share by Regions: 2020 VS 2027 Figure 16. Global Pharmacogenomics (PGx) Market Share by Regions (2022-2027) Figure 17. Global Pharmacogenomics (PGx) Market Share by Players in 2020 Figure 18. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacogenomics (PGx) as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2020 Figure 20. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2016-2021) Figure 21. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2022-2027) Figure 22. North America Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Pharmacogenomics (PGx) Market Share by Type (2016-2027) Figure 24. North America Pharmacogenomics (PGx) Market Share by Application (2016-2027) Figure 25. North America Pharmacogenomics (PGx) Market Share by Country (2016-2027) Figure 26. United States Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Pharmacogenomics (PGx) Market Share by Type (2016-2027) Figure 30. Europe Pharmacogenomics (PGx) Market Share by Application (2016-2027) Figure 31. Europe Pharmacogenomics (PGx) Market Share by Country (2016-2027) Figure 32. Germany Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Pharmacogenomics (PGx) Market Share by Type (2016-2027) Figure 40. Asia-Pacific Pharmacogenomics (PGx) Market Share by Application (2016-2027) Figure 41. Asia-Pacific Pharmacogenomics (PGx) Market Share by Region (2016-2027) Figure 42. China Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Pharmacogenomics (PGx) Market Share by Type (2016-2027) Figure 50. Latin America Pharmacogenomics (PGx) Market Share by Application (2016-2027) Figure 51. Latin America Pharmacogenomics (PGx) Market Share by Country (2016-2027) Figure 52. Mexico Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Pharmacogenomics (PGx) Market Share by Type (2016-2027) Figure 56. Middle East & Africa Pharmacogenomics (PGx) Market Share by Application (2016-2027) Figure 57. Middle East & Africa Pharmacogenomics (PGx) Market Share by Country (2016-2027) Figure 58. Turkey Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Pharmacogenomics (PGx) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 62. Affymetrix, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 63. Assurex Health, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 64. Astrazeneca Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 65. GeneDX Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 66. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 67. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 68. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 69. Pathway Genomics Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 70. Pfizer, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 71. Qiagen, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 72. Rocheg Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 73. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 74. Thermo Fisher Scientific Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 75. Transgenomic, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Abbott Laboratories Affymetrix, Inc. Assurex Health, Inc Astrazeneca GeneDX Illumina, Inc. Laboratory Corporation of America Holdings Myriad Genetics, Inc. Pathway Genomics Pfizer, Inc Qiagen, Inc. Rocheg Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific Transgenomic, Inc.